Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Extended-release pharmacotherapy for opioid use disorder (EXPO): protocol for an open-label randomised controlled trial of the effectiveness and cost-effectiveness of injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone.
Marsden J, Kelleher M, Hoare Z, Hughes D, Bisla J, Cape A, Cowden F, Day E, Dewhurst J, Evans R, Hearn A, Kelly J, Lowry N, McCusker M, Murphy C, Murray R, Myton T, Quarshie S, Scott G, Turner S, Vanderwaal R, Wareham A, Gilvarry E, Mitcheson L. Marsden J, et al. Among authors: lowry n. Trials. 2022 Aug 19;23(1):697. doi: 10.1186/s13063-022-06595-0. Trials. 2022. PMID: 35986418 Free PMC article.
Experience and response to a randomised controlled trial of extended-release injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone for opioid use disorder: protocol for a mixed-methods evaluation.
Lowry N, Cowden F, Day E, Gilvarry E, Johnstone S, Murray R, Kelleher M, Mitcheson L, Marsden J. Lowry N, et al. BMJ Open. 2022 Oct 21;12(10):e067194. doi: 10.1136/bmjopen-2022-067194. BMJ Open. 2022. PMID: 36270754 Free PMC article.
Superiority and cost-effectiveness of monthly extended-release buprenorphine versus daily standard of care medication: a pragmatic, parallel-group, open-label, multicentre, randomised, controlled, phase 3 trial.
Marsden J, Kelleher M, Gilvarry E, Mitcheson L, Bisla J, Cape A, Cowden F, Day E, Dewhurst J, Evans R, Hardy W, Hearn A, Kelly J, Lowry N, McCusker M, Murphy C, Murray R, Myton T, Quarshie S, Vanderwaal R, Wareham A, Hughes D, Hoare Z. Marsden J, et al. Among authors: lowry n. EClinicalMedicine. 2023 Nov 17;66:102311. doi: 10.1016/j.eclinm.2023.102311. eCollection 2023 Dec. EClinicalMedicine. 2023. PMID: 38045803 Free PMC article.
Childhood obesity in the ED: A prospective Australian study.
Marsh R, Gill S, Lowry N, Hayden G, Ryan M, Gwini SM, Allender S, Stella J. Marsh R, et al. Among authors: lowry n. Emerg Med Australas. 2024 Apr 22. doi: 10.1111/1742-6723.14414. Online ahead of print. Emerg Med Australas. 2024. PMID: 38649794
Chronic Pain, Hopelessness, and Suicide Risk Among Adult Medical Inpatients.
Ryan PC, Lowry NJ, Boudreaux E, Snyder DJ, Claassen CA, Harrington CJ, Jobes DA, Bridge JA, Pao M, Horowitz LM. Ryan PC, et al. Among authors: lowry nj. J Acad Consult Liaison Psychiatry. 2024 Mar-Apr;65(2):126-135. doi: 10.1016/j.jaclp.2023.11.686. Epub 2023 Nov 27. J Acad Consult Liaison Psychiatry. 2024. PMID: 38030078
85 results